Supreme Court confirms methods of medical treatment are unpatentable in Canada and clarifies test
The SCC addressed the parties’ arguments regarding the Canadian prohibition on patenting methods of medical treatment. Pharmascience brought the appeal seeking to...Read More
New Biosimilar Guidance Document: Simplifying process for biosimilars
On May 19, 2026, Health Canada published a revised Guidance on Information and Submission Requirements for Biosimilar Biologic Drugs. Health Canada also...Read More